UK altnets count cost of ‘gold rush’ end after collective losses surpass £1bn
Alternative network providers under pressure to demonstrate they can be profitable businesses not just builders ...
Buyer splashes out $1.3m for Tokyo new year tuna
The top bidder at a Tokyo fish market said they paid $1.3 million for a tuna on Sunday, the second highest price ever paid at ...
Digital accessibility: Building an Internet for all should become a business imperative
An unwelcomed business trend in the U.S. during 2024 has been with the number of ADA lawsuits and increasing consumer demand for inclusivity. This has led some market commentators to remark that ...
Pharmaceutical Technology7h
Irodanoprost by Mesentech for Duchenne Muscular Dystrophy: Likelihood of Approval
Irodanoprost is under clinical development by Mesentech and currently in Phase I for Duchenne Muscular Dystrophy.
Pharmaceutical Technology8h
Tevimbra by BeiGene for Marginal Zone B-cell Lymphoma: Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Marginal Zone B-cell Lymphoma.